Kinase targets in renal-cell carcinomas: reassessing the old and discovering the new.
about
Targeted therapy for advanced renal cell carcinomaA comparison of Ku0063794, a dual mTORC1 and mTORC2 inhibitor, and temsirolimus in preclinical renal cell carcinoma modelsRASSF6 promotes p21(Cip1/Waf1)-dependent cell cycle arrest and apoptosis through activation of the JNK/SAPK pathway in clear cell renal cell carcinoma.A review on various targeted anticancer therapies.Targeted therapies for non-clear renal cell carcinoma.Prognostic value of EZH2 expression and activity in renal cell carcinoma: a prospective study.Impact of genetics on the diagnosis and treatment of renal cancer.Chronic inflammation and immunologic-based constraints in malignant disease.Clinical application of development of nonantibiotic macrolides that correct inflammation-driven immune dysfunction in inflammatory skin diseasesDecreased Expression of SETD2 Predicts Unfavorable Prognosis in Patients With Nonmetastatic Clear-Cell Renal Cell Carcinoma.Non-clear cell renal cell carcinoma: how new biological insight may lead to new therapeutic modalities.Current and future directions in mammalian target of rapamycin inhibitors development.Optimizing treatment of metastatic renal cell carcinoma by changing mechanism of action.Targeted therapies in metastatic renal cell carcinoma: overview of the past year.Optimizing further treatment choices in short- and long-term responders to first-line therapy for patients with advanced renal cell carcinoma.Constitutional genetic variants as predictors of antiangiogenic therapy outcome in renal cell carcinoma.Total synthesis and biological evaluation of (-)-englerin A and B: synthesis of analogues with improved activity profile.The relationship of kinase insert domain receptor gene polymorphisms and clinical outcome in advanced hepatocellular carcinoma patients treated with sorafenib.Prognostic significance of p21-activated kinase 6 expression in patients with clear cell renal cell carcinoma.PKCα is involved in the progression of kidney carcinoma through regulating netrin-1/UNC5B signaling pathway.
P2860
Q24242946-512CF02A-61CF-45C3-832F-48F69DB47B20Q28485220-803171C1-1206-40C6-A047-FD8484A1B701Q33728900-FC114BF2-5B54-4999-B752-3FB78D9E246DQ34164735-14C0604B-563D-4AFE-9E4D-A5CEAF93878BQ34412479-BCB7C0D2-0221-4F9D-B751-ED72FD6D62F6Q35060552-B1E91C64-83F8-4BED-A3F7-F6466F336C19Q35189579-D459F6F9-CC17-40E3-BA0E-C86AC9CC8F4FQ35575974-3FF6B59A-88F9-45E4-8017-4E53448CF245Q36425959-5F53428B-2DF6-48D6-B3B1-D69375450261Q37016755-1F710B6E-6967-4838-BC83-02227E8AB68EQ37836508-48F2F6D3-1315-4FCD-896C-DEC2DC75542CQ37836904-A5107E99-BC51-4EC6-B419-025A719A19E0Q37866796-DC6EAE8A-C6CA-4C30-AF0C-7522358A9030Q37964565-9FE72AC7-A77E-4C8E-94BC-8E72C7C9C6EEQ38048822-F289C5A5-57FC-4092-B39A-3536E63F97AAQ38059507-9ED2404B-7605-4967-8354-80B7BCBF150EQ39562474-66335945-39AC-488D-A761-2879AA0B5DC5Q44479261-CDE814DA-00A0-4AC2-8FF9-25BE4DBE23A9Q50700443-32520488-D388-4D24-936A-2EDC2B51DDA7Q51822608-3A6DB9B4-D172-4F3E-A57A-D8AEF39F9A9D
P2860
Kinase targets in renal-cell carcinomas: reassessing the old and discovering the new.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 08 April 2010
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Kinase targets in renal-cell carcinomas: reassessing the old and discovering the new.
@en
Kinase targets in renal-cell carcinomas: reassessing the old and discovering the new.
@nl
type
label
Kinase targets in renal-cell carcinomas: reassessing the old and discovering the new.
@en
Kinase targets in renal-cell carcinomas: reassessing the old and discovering the new.
@nl
prefLabel
Kinase targets in renal-cell carcinomas: reassessing the old and discovering the new.
@en
Kinase targets in renal-cell carcinomas: reassessing the old and discovering the new.
@nl
P1433
P1476
Kinase targets in renal-cell carcinomas: reassessing the old and discovering the new.
@en
P2093
Kyle A Furge
P304
P356
10.1016/S1470-2045(09)70380-8
P577
2010-04-08T00:00:00Z